Resistant and extrapulmonary tuberculosis: two challenges for today’s clinician

Tuberculosis resistente y extrapulmonar: dos retos para el médico de hoy

Published 2013-09-30

Open | Download
PDF (Spanish) FLIP
Issue
Vol. 25 No. 3 (2013)
Section
Editorial
How to Cite
Resistant and extrapulmonary tuberculosis: two challenges for today’s clinician.
rev. colomb. neumol. [Internet]. 2013 Sep. 30 [cited 2024 Nov. 22];25(3). Disponible en: https://doi.org/10.30789/rcneumologia.v25.n3.2013.105
DOI

https://doi.org/10.30789/rcneumologia.v25.n3.2013.105
Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Juan Carlos Rojas Puentes, MD.
    Show authors biography

    Juan Carlos Rojas Puentes, MD.

    Internista, Neumólogo. Pereira, Colombia.

    Article visits 341 | PDF visits 355

    Downloads

    Download data is not yet available.
    1. Farga V, Caminero J. Tuberculosis. Tercera edición 2011. Santiago,
    2. Buenos Aires: Editorial Mediterráneo.
    3. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608-16.
    4. Pandie S, Peter J, Kerbelker Z. BMC Medicine. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study. BMC Medicine 2014;12:101.
    5. Torres C, Awad C, Dennis R. Guía para el manejo programático de pacientes con tuberculosis farmacorresistente en Colombia 2012. Bogotá: Ministerio de la Protección Social, Fundación Neumológica Colombiana, Instituto Nacional de Salud. Organización Panamericana de la Salud.
    6. Keshavjee S, Farmer P. Tuberculosis, Drug resistance, and the history of modern medicine. N Engl J Med. 2012;367:931-6.
    7. Caminero J. Multidrug-resistant tuberculosis: epidemiology, risk factor and case finding. Int J Tuberc Lung Dis. 2010;14:382-390.
    8. Yew W, Zhang Y. Mechanism of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009;13:1320-1330.
    9. Cuevas C; Zenteno R. tuberculosis drogorresistente: mecanismos moleculares y métodos diagnósticos. Enferm Infecc Microbiol Clin. 2010;28:6221-628.
    10. Van rie A, Page L, Scott L. Xpert MTB/RIF for point of care diagnosis of TB in high HIV burden, resource–limited countries: hype o hope? Expert Rev Mol Diagn. 20101;10:937-946.
    11. Lawn S, Nicol M, Xpert MTB/RIF assay: Development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6:1067-1082.
    12. Boehme C, Nabeta P, Hillemann D. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-1015.
    13. Arentz M, Sorensen B, Horne DJ, Walson JL. Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis. Plos One. 2013;8:e76533.
    14. Vigneshwaran M, Wang S, Inci F, De Libero G. Emerging technologies for monitoring drug-resistant tuberculosis and the point-of-care. Adv Drug Deliv Rev. 2014 (in Press).
    15. Georghiou S, Magana M, Garfein R, Catanzaro D, Cantanzaro A. Evaluation of genetic mutations associates with Mycobacterium tuberculosis resistance to amikacina, kanamycin, capreomycin: a systematic review. Plos ONE. 2012;7:e33275.

    Information

    Journal history

    Keywords

    QR code

    Funding

    Support + Info: Here

     

     

    Directories and indexes

    Google Scholar profile

    Most read in the last 30 days

    Current Issue

    Sistema OJS 3.4.0.7 - Metabiblioteca |